サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1376012

プレシジョンメディシンの市場規模、シェア、動向分析レポート：用途別、最終用途別、地域別、セグメント予測、2023年～2030年

Precision Medicine Market Size, Share & Trends Analysis Report By Application (Diagnostics (Genetic Tests, Esoteric Tests)), Therapeutics (Pharmaceuticals, Medical Devices), By End Use, By Region, And Segment Forecasts, 2023 - 2030
出版日: | 発行: Grand View Research | ページ情報: 英文 145 Pages | 納期: 2～10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
プレシジョンメディシンの市場規模、シェア、動向分析レポート：用途別、最終用途別、地域別、セグメント予測、2023年～2030年
出版日: 2023年10月25日
発行: Grand View Research
ページ情報: 英文 145 Pages
納期: 2～10営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

プレシジョンメディシン市場の成長と動向：

Grand View Research, Inc.の最新レポートによると、世界のプレシジョンメディシン市場規模は2030年までに1,607億8,000万米ドルに達し、2023年から2030年までのCAGRは10.7％で成長すると予測されています。

費用対効果の高いゲノム・分子生物学的検査法のイントロダクション、がんや希少疾患の有病率の増加、プレシジョンメディシンにおけるビッグデータの利用の高まりといった動向は、市場成長を後押しする主要因の一部です。

ヒトゲノムプロジェクトは、全ゲノム配列決定や標的配列決定などの素晴らしい最先端技術を導入しました。これらの技術は、ゲノムの研究や、様々な病気の治療のための個別化治療の創出のために研究者によって使用されています。今日、腫瘍学、免疫学、神経学などの分野における疾患の流行は、世界中で急速に増加しています。

研究者、ヘルスケア専門家、そして大手製薬会社やバイオテクノロジー企業は、患者の健康のために新たな治療法の選択肢を見出すために協力しています。現在、さまざまな種類のがんを治療するために、多くの治療法や薬剤が臨床試験中です。さらに、研究者たちは、がん以外の疾患領域における精密医薬品や診断法の開発にも関心を示しています。

治療とは別に、診断分野もここ数年で急成長を遂げています。次世代シーケンシング（NGS）、バイオマーカー、コンパニオン診断、難解な検査の使用は、医薬品の処方パターンを変化させ、影響を与える可能性があります。個別化された医薬品は、今後20年以内に大成功を収める可能性が非常に高く、以前は不可能だった少数の難病の治療や治癒を可能にする能力を持っています。

この分野の成長には、政府や規制機関の関与が非常に重要な役割を果たしています。2015年、当時の米国政府はプレシジョンメディシン・イニシアティブの立ち上げを発表しました。翌年、中国は「中国プレシジョンメディシンイニシアティブ」を発足させました。これは15年計画で、同国を精密治療開発のリーダーとして構築することを目的としています。

現在、バイオテクノロジー企業や製薬企業の改善パイプラインにある医薬品の40％以上がバイオマーカーを組み込んでいます。同概要では、過去5年間にいくつかのバイオ製薬企業が共同事業やジョイントベンチャーを行っており、今後数年間も継続する見込みであることも推奨しています。このように、診断・治療プレシジョンメディシン市場は計り知れない可能性を秘めており、急速に患者ケアの基本分野へと変貌しつつあります。

プレシジョンメディシン市場レポートハイライト

  • 遺伝子配列決定、バイオマーカー、ビッグデータ解析、コンパニオン診断などの技術が、今後数年間この市場を牽引すると予測されます。
  • 最終用途別では、臨床検査室が2022年の市場で圧倒的なシェアを占める。一方、在宅医療検査分野は、その迅速性、効率性、利便性から急成長を遂げています。
  • 適応領域別では、がん領域の治療用精密医薬品が2022年に最大の市場シェアを占めました。しかし、非腫瘍性疾患に対する精密医薬品の開発へと研究者の焦点が変わってきています。その結果、免疫疾患、遺伝性疾患、希少疾患への注目が高まっています。
  • 北米市場は現在最大のシェアを占めており、予測期間中にさらに成長すると予想されています。同市場は主に、政府による支援政策やイニシアティブ、市場プレイヤーの強い存在感によって牽引されています。アジア太平洋地域は、この市場で最も急成長している地域となる見込みです。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 プレシジョンメディシン市場の変数、動向、範囲

  • 市場系統の見通し
    • 親市場の見通し
    • 関連/付随市場の見通し
  • 普及と成長の見通しマッピング
  • 市場力学
    • 市場促進要因分析
    • 市場抑制要因分析
  • プレシジョンメディシン市場分析ツール
    • 業界分析- ポーターのファイブフォース分析
    • PESTEL分析

第4章 プレシジョンメディシン：用途の推定・動向分析

  • プレシジョンメディシン市場：重要なポイント
  • プレシジョンメディシン市場：動向と市場シェア分析、2022年と2030年
  • 診断
    • 診断市場推計・予測、2018年から2030年まで
    • 遺伝子検査
    • 消費者への直接テスト
    • 難解なテスト
    • その他
  • 治療
    • 治療薬市場推計・予測、2018年から2030年まで
    • 医薬品
    • 医療機器
    • その他

第5章 プレシジョンメディシン：最終用途の推定・動向分析

  • プレシジョンメディシン市場：重要なポイント
  • プレシジョンメディシン市場：動向と市場シェア分析、2022年と2030年
  • ホームケア
  • 病院
  • 臨床検査室
  • その他

第6章 プレシジョンメディシン市場：地域の推定・動向分析

  • 地域別の見通し
  • 地域別のプレシジョンメディシン市場：主要マーケットプレースの要点
  • 北米
    • 市場推計・予測、2018～2030年
    • 米国
    • カナダ
  • 欧州
    • 英国
    • ドイツ
    • フランス
    • イタリア
    • スペイン
    • スウェーデン
    • ノルウェー
    • デンマーク
  • アジア太平洋地域
    • 日本
    • 中国
    • インド
    • オーストラリア
    • タイ
    • 韓国
  • ラテンアメリカ
    • ブラジル
    • メキシコ
    • アルゼンチン
  • 中東・アフリカ
    • サウジアラビア
    • 南アフリカ
    • アラブ首長国連邦
    • クウェート

第7章 競合情勢

  • 主要市場参入企業による最近の動向と影響分析
  • 市場参入企業の分類
    • F. Hoffmann-La Roche Ltd.-Foundation Medicine
    • Siemens Healthineers
    • Janssen Pharmaceuticals
    • Illumina
    • Quest Diagnostics Incorporated.
    • 23andMe, Inc.
    • NeoDiagnostix, Inc.,
    • IBM Watson
    • Myriad Genetics Inc.
    • Medtronic
    • GE Healthcare
    • Abbott Laboratories
    • Dako A/S
    • Biogen
    • Precision Biologics Incorporated
    • Qiagen Incorporated
図表

List of Tables

  • Table 1 List of Abbreviations
  • Table 2 North America precision medicine market, by application, 2018 - 2030 (USD Million)
  • Table 3 North America precision medicine market, by end-use, 2018 - 2030 (USD Million)
  • Table 4 North America precision medicine market, by region, 2018 - 2030 (USD Million)
  • Table 5 U.S. precision medicine market, by application, 2018 - 2030 (USD Million)
  • Table 6 U.S. precision medicine market, by end-use, 2018 - 2030 (USD Million)
  • Table 7 Canada precision medicine market, by application, 2018 - 2030 (USD Million)
  • Table 8 Canada precision medicine market, by end-use, 2018 - 2030 (USD Million)
  • Table 9 Europe precision medicine market, by application, 2018 - 2030 (USD Million)
  • Table 10 Europe precision medicine market, by end-use, 2018 - 2030 (USD Million)
  • Table 11 Europe precision medicine market, by region, 2018 - 2030 (USD Million)
  • Table 12 Germany precision medicine market, by application, 2018 - 2030 (USD Million)
  • Table 13 Germany precision medicine market, by end-use, 2018 - 2030 (USD Million)
  • Table 14 UK precision medicine market, by application, 2018 - 2030 (USD Million)
  • Table 15 UK precision medicine market, by end-use, 2018 - 2030 (USD Million)
  • Table 16 France precision medicine market, by application, 2018 - 2030 (USD Million)
  • Table 17 France precision medicine market, by end-use, 2018 - 2030 (USD Million)
  • Table 18 Italy precision medicine market, by application, 2018 - 2030 (USD Million)
  • Table 19 Italy precision medicine market, by end-use, 2018 - 2030 (USD Million)
  • Table 20 Spain precision medicine market, by application, 2018 - 2030 (USD Million)
  • Table 21 Spain precision medicine market, by end-use, 2018 - 2030 (USD Million)
  • Table 22 Sweden precision medicine market, by application, 2018 - 2030 (USD Million)
  • Table 23 Sweden precision medicine market, by end-use, 2018 - 2030 (USD Million)
  • Table 24 Norway precision medicine market, by application, 2018 - 2030 (USD Million)
  • Table 25 Norway precision medicine market, by end-use, 2018 - 2030 (USD Million)
  • Table 26 Denmark precision medicine market, by application, 2018 - 2030 (USD Million)
  • Table 27 Denmark precision medicine market, by end-use, 2018 - 2030 (USD Million)
  • Table 28 Asia Pacific precision medicine market, by application, 2018 - 2030 (USD Million)
  • Table 29 Asia Pacific precision medicine market, by end-use, 2018 - 2030 (USD Million)
  • Table 30 Asia Pacific precision medicine market, by region, 2018 - 2030 (USD Million)
  • Table 31 China precision medicine market, by application, 2018 - 2030 (USD Million)
  • Table 32 China precision medicine market, by end-use, 2018 - 2030 (USD Million)
  • Table 33 Japan precision medicine market, by application, 2018 - 2030 (USD Million)
  • Table 34 Japan precision medicine market, by end-use, 2018 - 2030 (USD Million)
  • Table 35 India precision medicine market, by application, 2018 - 2030 (USD Million)
  • Table 36 India precision medicine market, by end-use, 2018 - 2030 (USD Million)
  • Table 37 Australia precision medicine market, by application, 2018 - 2030 (USD Million)
  • Table 38 Australia precision medicine market, by end-use, 2018 - 2030 (USD Million)
  • Table 39 Thailand precision medicine market, by application, 2018 - 2030 (USD Million)
  • Table 40 Thailand precision medicine market, by end-use, 2018 - 2030 (USD Million)
  • Table 41 South Korea precision medicine market, by application, 2018 - 2030 (USD Million)
  • Table 42 South Korea precision medicine market, by end-use, 2018 - 2030 (USD Million)
  • Table 43 Latin America precision medicine market, by application, 2018 - 2030 (USD Million)
  • Table 44 Latin America precision medicine market, by end-use, 2018 - 2030 (USD Million)
  • Table 45 Latin America precision medicine market, by region, 2018 - 2030 (USD Million)
  • Table 46 Brazil precision medicine market, by application, 2018 - 2030 (USD Million)
  • Table 47 Brazil precision medicine market, by end-use, 2018 - 2030 (USD Million)
  • Table 48 Mexico precision medicine market, by application, 2018 - 2030 (USD Million)
  • Table 49 Mexico precision medicine market, by end-use, 2018 - 2030 (USD Million)
  • Table 50 Argentina precision medicine market, by application, 2018 - 2030 (USD Million)
  • Table 51 Argentina precision medicine market, by end-use, 2018 - 2030 (USD Million)
  • Table 52 Middle East and Africa precision medicine market, by application, 2018 - 2030 (USD Million)
  • Table 53 Middle East and Africa precision medicine market, by end-use, 2018 - 2030 (USD Million)
  • Table 54 Middle East and Africa precision medicine market, by region, 2018 - 2030 (USD Million)
  • Table 55 South Africa precision medicine market, by application, 2018 - 2030 (USD Million)
  • Table 56 South Africa precision medicine market, by end-use, 2018 - 2030 (USD Million)
  • Table 57 Saudi Arabia precision medicine market, by application, 2018 - 2030 (USD Million)
  • Table 58 Saudi Arabia precision medicine market, by end-use, 2018 - 2030 (USD Million)
  • Table 59 UAE precision medicine market, by application, 2018 - 2030 (USD Million)
  • Table 60 UAE precision medicine market, by end-use, 2018 - 2030 (USD Million)
  • Table 61 Kuwait precision medicine market, by application, 2018 - 2030 (USD Million)
  • Table 62 Kuwait precision medicine market, by end-use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value-chain-based sizing & forecasting
  • Fig. 6 QFD modeling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 Precision medicine: Market outlook
  • Fig. 9 Precision medicine: Competitive insights
  • Fig. 10 Parent market outlook
  • Fig. 11 Related/ancillary market outlook
  • Fig. 12 Penetration and growth prospect mapping
  • Fig. 13 Industry value chain analysis
  • Fig. 14 Precision medicine market driver impact
  • Fig. 15 Precision medicine market restraint impact
  • Fig. 16 Precision medicine market strategic initiatives analysis
  • Fig. 17 Precision medicine market: Application movement analysis
  • Fig. 18 Precision medicine market: Application outlook and key takeaways
  • Fig. 19 Diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 20 Genetic tests market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 21 Direct to consumer tests market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 22 Esoteric tests market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 23 Others market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 24 Therapeutics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 25 Pharmaceuticals market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 26 Oncology market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 27 Respiratory diseases market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 28 Skin diseases market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 29 CNS disorders market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 30 Immunology market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 31 Genetic diseases market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 32 Others market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 33 Medical devices market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 34 Others market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 35 Precision medicine market: End-use movement analysis
  • Fig. 36 Precision medicine market: End-use outlook and key takeaways
  • Fig. 37 Home care market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 38 Hospitals market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 39 Clinical laboratories market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 40 Others market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 41 Global precision medicine market: Regional movement analysis
  • Fig. 42 Global precision medicine market: Regional outlook and key takeaways
  • Fig. 43 North America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 44 U.S. market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 45 Canada market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 46 Europe market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 47 UK market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 48 Germany market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 49 France market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 50 Italy market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 51 Spain market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 52 Sweden market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 53 Norway market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 54 Denmark market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 55 Asia Pacific market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 56 Japan market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 57 China market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 58 India market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 59 Australia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 60 Thailand market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 61 South Korea market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 62 Latin America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 63 Brazil market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 64 Mexico market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 65 Argentina market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 66 Middle East and Africa. market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 67 Saudi Arabia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 68 South Africa market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 69 UAE market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 70 Kuwait market estimates and forecasts, 2018 - 2030 (USD Million)
目次
Product Code: GVR-2-68038-612-7

Precision Medicine Market Growth & Trends:

The global precision medicine market size is expected to reach USD 160.78 billion by 2030 growing at a CAGR of 10.7% from 2023 to 2030, according to a new report by Grand View Research, Inc.. Trends such as introduction of cost-effective genomic and molecular biology testing methods, increasing prevalence of cancer and rare diseases, and rising use of big data in precision medicine are some of the key factors boosting market growth.

The Human Genome Project introduced some marvelous cutting-edge techniques such as whole genome sequencing and targeted sequencing. These technologies are being used by researchers for the study of genomes and creation of personalized therapies for treatment of various illnesses. Today, the prevalence of diseases in areas such as oncology, immunology, and neurology has rapidly increased across the globe.

Researchers, healthcare professionals, and big pharma and biotech companies are working together to recognize new focused treatments options for the wellbeing of patients. Currently, there are many therapies and drugs under clinical trials for treatment of different types of cancers. Moreover, researchers have also shown an inclination toward development of precision medicines and diagnostics in non-oncologic disease areas.

Apart from therapeutics, the diagnostics field has also witnessed rapid growth in the past few years. The use of next generation sequencing (NGS), biomarkers, companion diagnostics, and esoteric tests can possibly change and affect prescription patterns of pharmaceutical medicines. Personalized medicines have very high chances of becoming a massive success in the next 20 years and have the capacity to treat and cure a few obstinate illnesses, which was not possible before.

Involvement of government and regulatory bodies has played a very important role in the growth of this field. In 2015, the then U.S. government announced the launch of the Precision Medicine Initiative. The following year, China launched the China Precision Medicine Initiative, which is a 15-year project that aims to build the country as a leader in development of precision therapies.

At present, more than 40% of the medications in biotech and pharmaceutical companies' improvement pipeline incorporate biomarkers. The overview likewise recommended that some biopharmaceutical organizations have collaborated and joint their ventures in the past five years and are expected to continue doing so in the coming years. The diagnostic and therapeutic precision medicine market thus holds immense potential and is quickly turning into a fundamental segment of patient care.

Precision Medicine Market Report Highlights:

  • Technologies such as gene sequencing, biomarkers, big data analytics, and companion diagnostics are anticipated to drive this market in the coming years
  • By end use, clinical labs held the dominant share in the market in 2022. The home care testing segment, on the other hand, has been witnessing rapid growth due to its speed, efficiency, and convenience
  • On the basis of indication area, therapeutic precision medicines for oncology held the largest market share in 2022. However, there has been a change in focus of researchers toward the development of precision medicines for non-oncologic diseases. This has resulted in greater focus on immunological, genetic, and rare diseases
  • The North America market currently holds the largest share and is expected to grow further during the forecast period. The market is primarily driven by supportive policies and initiatives by the government and strong presence of market players. Asia Pacific is expected to emerge as the fastest growing region in this market

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Application
    • 1.1.2. End-use
    • 1.1.3. Regional scope
    • 1.1.4. Estimates and forecast timeline
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
  • 1.4. Information or Data Analysis
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Application outlook
    • 2.2.2. End-use outlook
    • 2.2.3. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Precision Medicine Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Market Dynamics
    • 3.3.1. Market Driver Analysis
    • 3.3.2. Market Restraint Analysis
  • 3.4. Precision Medicine Market Analysis Tools
    • 3.4.1. Industry Analysis - Porter's
      • 3.4.1.1. Supplier power
      • 3.4.1.2. Buyer power
      • 3.4.1.3. Substitution threat
      • 3.4.1.4. Threat of new entrant
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Technological landscape
      • 3.4.2.3. Economic landscape

Chapter 4. Precision Medicine: Application Estimates & Trend Analysis

  • 4.1. Precision Medicine Market: Key Takeaways
  • 4.2. Precision Medicine Market: Movement & Market Share Analysis, 2022 & 2030
  • 4.3. Diagnostics
    • 4.3.1. Diagnostics market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.3.2. Genetic tests
      • 4.3.2.1. Genetic tests market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.3.3. Direct to consumer tests
      • 4.3.3.1. Direct to consumer tests market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.3.4. Esoteric tests
      • 4.3.4.1. Esoteric tests market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.3.5. Others
      • 4.3.5.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.4. Therapeutics
    • 4.4.1. Therapeutics market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.4.2. Pharmaceuticals
      • 4.4.2.1. Pharmaceuticals market estimates and forecasts, 2018 to 2030 (USD Million)
      • 4.4.2.2. Oncology
      • 4.4.2.2.1. Oncology market estimates and forecasts, 2018 to 2030 (USD Million)
      • 4.4.2.3. Respiratory diseases
      • 4.4.2.3.1. Respiratory diseases market estimates and forecasts, 2018 to 2030 (USD Million)
      • 4.4.2.4. Skin diseases
      • 4.4.2.4.1. Skin diseases market estimates and forecasts, 2018 to 2030 (USD Million)
      • 4.4.2.5. CNS disorders
      • 4.4.2.5.1. CNS disorders market estimates and forecasts, 2018 to 2030 (USD Million)
      • 4.4.2.6. Immunology
      • 4.4.2.6.1. Immunology market estimates and forecasts, 2018 to 2030 (USD Million)
      • 4.4.2.7. Genetic diseases
      • 4.4.2.7.1. Genetic diseases market estimates and forecasts, 2018 to 2030 (USD Million)
      • 4.4.2.8. Others
      • 4.4.2.8.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.4.3. Medical Devices
      • 4.4.3.1. Medical Devices market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.4.4. Others
      • 4.4.4.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 5. Precision Medicine: End Use Estimates & Trend Analysis

  • 5.1. Precision Medicine Market: Key Takeaways
  • 5.2. Precision Medicine Market: Movement & Market Share Analysis, 2022 & 2030
  • 5.3. Home Care
    • 5.3.1. Home care market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.4. Hospitals
    • 5.4.1. Hospitals market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.5. Clinical Laboratories
    • 5.5.1. Clinical laboratories market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.6. Others
    • 5.6.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 6. Precision Medicine Market: Regional Estimates & Trend Analysis

  • 6.1. Regional Outlook
  • 6.2. Precision Medicine Market by Region: Key Marketplace Takeaway
  • 6.3. North America
    • 6.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.3.2. U.S.
      • 6.3.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.3.3. Canada
      • 6.3.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 6.4. Europe
    • 6.4.1. UK
      • 6.4.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.2. Germany
      • 6.4.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.3. France
      • 6.4.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.4. Italy
      • 6.4.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.5. Spain
      • 6.4.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.6. Sweden
      • 6.4.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.7. Norway
      • 6.4.7.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.8. Denmark
      • 6.4.8.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 6.5. Asia Pacific
    • 6.5.1. Japan
      • 6.5.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.5.2. China
      • 6.5.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.5.3. India
      • 6.5.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.5.4. Australia
      • 6.5.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.5.5. Thailand
      • 6.5.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.5.6. South Korea
      • 6.5.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 6.6. Latin America
    • 6.6.1. Brazil
      • 6.6.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.6.2. Mexico
      • 6.6.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.6.3. Argentina
      • 6.6.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 6.7. MEA
    • 6.7.1. Saudi Arabia
      • 6.7.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.7.2. South Africa
      • 6.7.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.7.3. UAE
      • 6.7.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.7.4. Kuwait
      • 6.7.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 7.2. Market Participant Categorization
    • 7.2.1. F. Hoffmann-La Roche Ltd.-Foundation Medicine
      • 7.2.1.1. Company overview
      • 7.2.1.2. Financial performance
      • 7.2.1.3. Product benchmarking
      • 7.2.1.4. Strategic initiatives
    • 7.2.2. Siemens Healthineers
      • 7.2.2.1. Company overview
      • 7.2.2.2. Financial performance
      • 7.2.2.3. Product benchmarking
      • 7.2.2.4. Strategic initiatives
    • 7.2.3. Janssen Pharmaceuticals
      • 7.2.3.1. Company overview
      • 7.2.3.2. Financial performance
      • 7.2.3.3. Product benchmarking
      • 7.2.3.4. Strategic initiatives
    • 7.2.4. Illumina
      • 7.2.4.1. Company overview
      • 7.2.4.2. Financial performance
      • 7.2.4.3. Product benchmarking
      • 7.2.4.4. Strategic initiatives
    • 7.2.5. Quest Diagnostics Incorporated.
      • 7.2.5.1. Company overview
      • 7.2.5.2. Financial performance
      • 7.2.5.3. Product benchmarking
      • 7.2.5.4. Strategic initiatives
    • 7.2.6. 23andMe, Inc.
      • 7.2.6.1. Company overview
      • 7.2.6.2. Financial performance
      • 7.2.6.3. Product benchmarking
      • 7.2.6.4. Strategic initiatives
    • 7.2.7. NeoDiagnostix, Inc.,
      • 7.2.7.1. Company overview
      • 7.2.7.2. Financial performance
      • 7.2.7.3. Product benchmarking
      • 7.2.7.4. Strategic initiatives
    • 7.2.8. IBM Watson
      • 7.2.8.1. Company overview
      • 7.2.8.2. Financial performance
      • 7.2.8.3. Product benchmarking
      • 7.2.8.4. Strategic initiatives
    • 7.2.9. Myriad Genetics Inc.
      • 7.2.9.1. Company overview
      • 7.2.9.2. Financial performance
      • 7.2.9.3. Product benchmarking
      • 7.2.9.4. Strategic initiatives
    • 7.2.10. Medtronic
      • 7.2.10.1. Company overview
      • 7.2.10.2. Financial performance
      • 7.2.10.3. Product benchmarking
      • 7.2.10.4. Strategic initiatives
    • 7.2.11. GE Healthcare
      • 7.2.11.1. Company overview
      • 7.2.11.2. Financial performance
      • 7.2.11.3. Product benchmarking
      • 7.2.11.4. Strategic initiatives
    • 7.2.12. Abbott Laboratories
      • 7.2.12.1. Company overview
      • 7.2.12.2. Financial performance
      • 7.2.12.3. Product benchmarking
      • 7.2.12.4. Strategic initiatives
    • 7.2.13. Dako A/S
      • 7.2.13.1. Company overview
      • 7.2.13.2. Financial performance
      • 7.2.13.3. Product benchmarking
      • 7.2.13.4. Strategic initiatives
    • 7.2.14. Biogen
      • 7.2.14.1. Company overview
      • 7.2.14.2. Financial performance
      • 7.2.14.3. Product benchmarking
      • 7.2.14.4. Strategic initiatives
    • 7.2.15. Precision Biologics Incorporated
      • 7.2.15.1. Company overview
      • 7.2.15.2. Financial performance
      • 7.2.15.3. Product benchmarking
      • 7.2.15.4. Strategic initiatives
    • 7.2.16. Qiagen Incorporated
      • 7.2.16.1. Company overview
      • 7.2.16.2. Financial performance
      • 7.2.16.3. Product benchmarking
      • 7.2.16.4. Strategic initiatives